SEC Form 4 · accession 0001547522-16-000257
IMMUCELL CORP /DE/ · ICCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph H Crabb
Officer — VP & Chief Scientific Officer · Director
Period of report
Jul 8, 2016
Accepted (ET)
Jul 12, 2016 · 12:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.10 per share | Jul 8, 2016 | S | 341 | $6.53 | D | 106,705 | D | |
| Common Stock, par value $0.10 per share | Jul 8, 2016 | S | 400 | $6.50 | D | 106,305 | D | |
| Common Stock, par value $0.10 per share | Jul 8, 2016 | S | 100 | $6.51 | D | 106,205 | D | |
| Common Stock, par value $0.10 per share | Jul 8, 2016 | S | 500 | $6.55 | D | 105,705 | D | |
| Common Stock, par value $0.10 per share | Jul 8, 2016 | S | 394 | $6.59 | D | 105,311 | D | |
| Common Stock, par value $0.10 per share | Jul 8, 2016 | S | 200 | $6.60 | D | 105,111 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported herein have been effectuated pursuant to a plan implemented by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.